Tradestie Institutional Equity Comparison Engine

AVR vs MXCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MXCT Overall Edge

MXCT Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MaxCyte, Inc. Common Stock (MXCT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AVR trades at N/M Forward P/E with -4880.4% operating margin (+21.0% YoY revenue) versus MXCT at N/M Forward P/E and -85.5% operating margin (+48.7% YoY). In options structure, AVR sits in BREAKDOWN (69th %ile IV; Dealer Gamma Walls on Pro) against MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AVR N/M vs MXCT N/M Fwd P/E
Growth & Margin Winner MXCT
Op Margin -4880.4% vs -85.5% ยท YoY +21.0% vs +48.7%
Momentum & Technical Winner MXCT
1Y +46.8% vs -19.4% ยท 52W Pos 22% vs 63%
Options & Structure Winner MXCT
BREAKDOWN (69th %ile IV) vs UNCLASSIFIED (N/A IV)
AVR NASDAQ
Anteris Technologies Global Corp. Common Stock
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$4.99
-1.96% 1D
Market Cap $496.2M
1M Return -16.83%
1Y Return +46.76%
Forward P/E N/M
Unified AI Score
42.0 / 100 HOLD
Tech 32.0 Fund 52.0 Flow 57.0 Mom 64.0
MXCT NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap $132.2M
1M Return -4.2%
1Y Return -19.41%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 46.0 Fund 52.0 Flow 62.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AVR +46.76% MXCT -19.41% Spread: +66.17 pp (AVR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AVR Revenue MXCT Revenue AVR Op. Margin MXCT Op. Margin Margin Edge
FY2019 N/A $10M N/A -93.7% MXCT
FY2020 N/A $20M N/A -71.6% MXCT
FY2021 N/A $20M N/A -84.3% MXCT
FY2022 N/A $30M N/A -95.2% MXCT
FY2023 N/A $20M N/A -247.7% MXCT
FY2024 $0M $20M -2899.4% -230.5% MXCT
FY2025 $0M $20M -4908.2% -247.6% MXCT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AVR (4) vs MXCT (4)
Institutional Metric AVR MXCT Criterion Row Winner
Market Capitalization Scale $496.2M $132.2M Larger Scale AVR
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +21.0% +48.7% Higher Growth MXCT
Operating Margin (TTM) Profitability -4880.4% -85.5% Higher Margin MXCT
Net Profit Margin Profitability 0.0% -81.4% Higher Margin AVR
Return on Equity (ROE) Capital Efficiency -93.3% -16.9% Higher ROE MXCT
52-Week Range Position Momentum 22% ($3โ€“$11) 63% ($1โ€“$2) Stronger Trend MXCT
Beta / 30D Volatility Risk Regime 1.49ฮฒ ยท 78% Vol 1.19ฮฒ ยท 96% Vol Lower Realized Risk AVR
Unified Institutional Score Composite Signal 42.0 / 100 (HOLD) 41.7 / 100 (SELL) Higher Composite AVR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AVR vs MXCT Buy Guide
AVR BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 69th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live AVR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MXCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MXCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AVR nor MXCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.